GLP-1 medications are not approved specifically for PMOS
Importantly, not everyone experiences these effects, and their intensity can vary widely
Kane RM, Williams SB, Reynolds K, et al
Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
Our Assessment Process Before starting any GLP-1 medication, the MedBridge team conducts a comprehensive assessment that includes: Reviewing your full medical history and current medications Evaluating for previous episodes of pancreatitis, personal or family history of certain endocrine tumors, and other potential contraindications Screening for pregnancy or breastfeeding, as GLP-1 therapy is not recommended in these cases GLP-1 medications are not intended for those seeking weight loss solely for cosmetic reasons or for patients with certain medical contraindications
Emerging digital technologies may allow for more informed and improved decision-making through better access to relevant data to manage glucose levels in PBH